Zevin Asset Management LLC Has $13.65 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Zevin Asset Management LLC lowered its position in Colgate-Palmolive (NYSE:CL) by 2.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 131,509 shares of the company’s stock after selling 2,987 shares during the quarter. Colgate-Palmolive accounts for about 2.1% of Zevin Asset Management LLC’s holdings, making the stock its 19th largest position. Zevin Asset Management LLC’s holdings in Colgate-Palmolive were worth $13,652,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of CL. Edgestream Partners L.P. bought a new stake in shares of Colgate-Palmolive in the 1st quarter worth approximately $1,571,000. Covestor Ltd lifted its position in shares of Colgate-Palmolive by 26.9% during the 1st quarter. Covestor Ltd now owns 1,015 shares of the company’s stock worth $91,000 after buying an additional 215 shares during the period. O Shaughnessy Asset Management LLC lifted its position in shares of Colgate-Palmolive by 22.9% during the 1st quarter. O Shaughnessy Asset Management LLC now owns 132,439 shares of the company’s stock worth $11,926,000 after buying an additional 24,695 shares during the period. Bessemer Group Inc. lifted its position in shares of Colgate-Palmolive by 69.2% during the 1st quarter. Bessemer Group Inc. now owns 43,475 shares of the company’s stock worth $3,915,000 after buying an additional 17,773 shares during the period. Finally, Arjuna Capital lifted its position in shares of Colgate-Palmolive by 149.0% during the 1st quarter. Arjuna Capital now owns 37,690 shares of the company’s stock worth $3,394,000 after buying an additional 22,555 shares during the period. Institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of NYSE CL opened at $93.56 on Monday. Colgate-Palmolive has a twelve month low of $75.17 and a twelve month high of $109.30. The business’s 50 day moving average price is $99.31 and its two-hundred day moving average price is $98.54. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The company has a market cap of $76.44 billion, a PE ratio of 26.81, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42.

Colgate-Palmolive Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 2.14%. The ex-dividend date was Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Insider Activity

In other news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Martina Hundmejean sold 2,313 shares of the firm’s stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total value of $240,228.18. Following the sale, the director now directly owns 11,755 shares in the company, valued at approximately $1,220,874.30. This trade represents a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on the company. Wells Fargo & Company cut their price objective on Colgate-Palmolive from $100.00 to $92.00 and set an “underweight” rating for the company in a research report on Monday, October 28th. Barclays lifted their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the company an “equal weight” rating in a research report on Monday, July 29th. Morgan Stanley lifted their price objective on Colgate-Palmolive from $103.00 to $111.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Sanford C. Bernstein lifted their price objective on Colgate-Palmolive from $100.00 to $103.00 and gave the company a “market perform” rating in a research report on Tuesday, July 30th. Finally, HSBC reiterated a “hold” rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. One analyst has rated the stock with a sell rating, nine have issued a hold rating and thirteen have given a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $105.11.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.